New Therapeutic Targets in Autoimmune Cholangiopathies-Reference-Cited by-同舟云学术

New Therapeutic Targets in Autoimmune Cholangiopathies

Published:2020-04-07 Issue: Volume:7 Page:
ISSN:2296-858X
Container-title:Frontiers in Medicine
language:
Short-container-title:Front. Med.

Author:

Gerussi Alessio,Lucà Martina,Cristoferi Laura,Ronca Vincenzo,Mancuso Clara,Milani Chiara,D'Amato Daphne,O'Donnell Sarah Elizabeth,Carbone Marco,Invernizzi Pietro

Publisher

Frontiers Media SA

Subject

General Medicine

Reference109 articles.

1. Global chemical effects of the microbiome include new bile-acid conjugations;Quinn;Nature.,2020

2. Update on FXR biology: promising therapeutic target?;Han;Int J Mol Sci.,2018

3. Towards precision medicine;Ashley;Nat Rev Genet.,2016

4. Upregulation of a basolateral FXR-dependent bile acid efflux transporter OSTα-OSTβ in cholestasis in humans and rodents;Boyer;Am J Physiol Liver Physiol.,2006

5. OSTα-OSTβ guards the ileal enterocyte from the accumulation of toxic levels of bile acids;Boyer;Cell Mol Gastroenterol Hepatol.,2018

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase separation of RNF214 promotes the progression of hepatocellular carcinoma;Cell Death & Disease;2024-07-05

2. Are Gender Differences Important for Autoimmune Liver Diseases?;Life;2024-04-12

3. Treatment of Primary Biliary Cholangitis including Transplantation;Clinics in Liver Disease;2024-02

4. Unveiling the Role of CD27+ Memory B Cells in Primary Biliary Cholangitis: A Mendelian Randomization Study;2024-01-08

5. Gut Microbiota: A Future Clinical Magic Bullet to Manifest Pathogenic Disease in the Current Future;Journal of Pure and Applied Microbiology;2023-03-02